![]() |
|
|
Vol. 302, Issue 1, 225-231, July 2002
Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Toyama (K.-i.H., M.T.); Core Research for Evolutional Science and Technology of Japan Science and Technology Corporation, Kawaguchi (K.-i.H., M.T., S.O., H.T., T.Te.); Department of Molecular Biopharmacy and Genetics, Graduate School of Pharmaceutical Sciences, and New Industry Creation Hatchery Center (S.O., H.T., T.Te.), Tohoku University, Sendai (S.O., H.T., S.S., T.Te.); Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo (Y.K., H.E.); and Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo, (M.N., T.Ts.) Japan
| |
Abstract |
|---|
|
|
|---|
The purpose of the present study was to elucidate the mechanism
of enhancement of L-cystine uptake at the blood-brain
barrier (BBB). The uptake of [14C]L-cystine
and [3H]L-glutamic acid (L-Glu)
was determined using a mouse brain endothelial cell line (MBEC4) as an
in vitro BBB model. The mRNA levels of L-cystine/L-Glu exchanger, system
xc
, which consists of xCT and 4F2hc, were
determined by quantitative real-time reverse transcription-polymerase
chain reaction analysis. The
[14C]L-cystine uptake by MBEC4 cells appeared
to be mediated via an Na+-independent saturable process.
The corresponding Michaelis-Menten constant
(Km) was 63.7 µM. In the presence of
L-Glu, there was competitive inhibition with an inhibition
constant (Ki) of 83.5 µM.
[3H]L-Glu uptake in the absence of
Na+ was saturable with a Km of
48.1 µM, and it exhibited competitive inhibition with a
Ki of 24.9 µM in the presence of
L-cystine. The mutual inhibition between
L-cystine and L-Glu and the type of inhibition
suggest that system xc
operates in MBEC4
cells. The xCT and 4F2hc mRNAs were expressed in MBEC4 cells and,
following diethyl maleate (DEM) treatment, the xCT mRNA level and
L-cystine uptake in MBEC4 cells were enhanced in parallel
with an increase in DEM concentration (up to 500 µM). Concomitantly,
the glutathione concentration in MBEC4 cells was increased. In
conclusion, system xc
-mediated
L-cystine uptake takes place in MBEC4 cells.
L-Cystine transport via system xc
at the BBB is likely to be induced under oxidative stress conditions following DEM treatment due to enhanced transcription of the xCT gene.
| |
Introduction |
|---|
|
|
|---|
L-Cystine
and L-glutamic acid (L-Glu) exchange
transporter, referred to as system
xc
, is composed of the heavy
chain of 4F2 cell surface antigen (4F2hc/CD98) and xCT protein (Sato et
al., 1999
). The physiological flux via system
xc
involves entry of
L-cystine and exit of L-Glu. Therefore, it plays a key role in the synthesis of glutathione because
L-cysteine (L-Cys), which is reduced from
L-cystine in the cells, is one of the rate-limiting
precursor amino acids for glutathione synthesis (Bannai and
Tateishi, 1986
). Under oxidative stress in the brain, L-cystine and/or L-Cys need to undergo influx
transport from the circulating blood to the brain across the
blood-brain barrier (BBB) to synthesize glutathione as a protection
against free radicals, peroxides, and other toxic compounds in the
central nervous system (CNS) (Meister and Anderson, 1983
). Glutathione
is present in a relatively high concentration (2 µmol/g brain) in
brain parenchymal cells (Folbergrova et al., 1979
), and its depletion
causes a serious disorder in the CNS (Skullerud et al., 1980
; Herrera
et al., 2001
). L-Cys is usually transported by a neutral
amino acid transporter, such as system L, which is present at the BBB
(Smith et al., 1987
; Boado et al., 1999
). However, the
concentration of L-Cys in the plasma (10-20 µM) is 10 times lower than that of L-cystine (100-200 µM)
(Dröge et al., 1991
).
Benrabh and Lefauconnier (1996)
suggested that system
xc
is not present at the BBB
under normal conditions since
[14C]L-Glu transport from blood to
the brain, studied using the brain perfusion technique, was not reduced
by L-cystine. Nevertheless, system
xc
is an inducible transporter
under oxidative stress conditions since xCT mRNA is induced by
treatment with diethyl maleate (DEM), lipopolysaccharide, and nitric
oxide donor (Sato et al., 1999
; Bridges et al., 2001
; Tomi et al.,
2002
). DEM is often used as a reagent to reduce intracellular
glutathione, i.e., oxidative stress condition, because it is relatively
less toxic than some other electrophilic agents (Bannai, 1984
; Sato et
al., 1999
; Kim et al., 2001
). Using in vivo integration plot analysis,
we recently reported that L-cystine uptake by brain and eye
is activated following a 12-h DEM infusion from the external carotid
artery, and this enhancement is inhibited in the presence of
L-Glu and L-
-aminoadipic acid
(L-AAA), substrates of system
xc
. This suggests that
L-cystine influx transport via system
xc
is activated by DEM at the
BBB and blood-retinal barrier in vivo (Hosoya et al., 2001
).
The purpose of this study was to elucidate the mechanism of
L-cystine uptake enhancement, as well as the expression and
regulation of system xc
under
oxidative stress, following DEM treatment using an immortalized mouse
brain capillary endothelial cell line, MBEC4, as an in vitro model of
the BBB (Tatsuta et al., 1992
).
| |
Materials and Methods |
|---|
|
|
|---|
Animals. Male ddY mice, weighing 25 to 30 g, were purchased from Charles River (Yokohama, Japan) and used as positive controls for reverse transcription-polymerase chain reaction (RT-PCR). The investigations using mice described in this report conformed to the guidelines of the Animal Care Committee, Graduate School of Pharmaceutical Sciences, Tohoku University.
Cell Culture.
MBEC4 cells (passages 10-40) were maintained
in Dulbecco's modified Eagle's medium (Nissui Co., Tokyo, Japan)
supplemented with 10% fetal bovine serum (Moregate, Bulimba,
Australia) (Tatsuta et al., 1992
) in the presence or absence of DEM
(Wako Pure Chemicals, Osaka, Japan), a sulfhydryl-reactive agent, at
37°C in a humidified atmosphere of 5% CO2/95% air.
RT-PCR Analysis. Total RNA was prepared from phosphate-buffered saline (PBS)-washed cells using Trizol reagent (Invitrogen, Carlsbad, CA). Single-strand cDNA was made from 1 µg of total RNA by RT using oligo(dT) primer. PCR was performed using GeneAmp (PCR system 9700; Applied Biosystems, Foster City, CA) with xCT- or 4F2hc-specific primers through 40 cycles of 94°C for 30 sec, 60°C for 1 min, and 72°C for 1 min. The sequences of the specific primers were as follows: the sense sequence was 5'-CCTGGCATTTGGACGCTACAT-3' and antisense sequence was 5'-TCAGAATTGCTGTGAGCTTGCA-3' for mouse xCT, and the sense sequence was 5'-CTCCCAGGAAGATTTTAAAGACCTTCT-3' and antisense sequence was 5'-TTCATTTTGGTGGCTACAATGTCAG-3' for mouse 4F2hc. The PCR products were separated by electrophoresis on an agarose gel in the presence of ethidium bromide and visualized using an imager (EPIPRO 7000; Aisin, Aichi, Japan). The PCR products of the expected length were then cloned into a plasmid vector using p-GEM-T Easy Vector system I (Promega, Madison, WI) and amplified in Escherichia coli. Several clones were then sequenced from both directions using a DNA sequencer (model 4200; LI-COR Biosciences, Lincoln, NE).
Quantitative Real-Time RT-PCR. Quantitative real-time RT-PCR analysis was performed using an ABI PRISM 7700 sequence detector system (Applied Biosystems) with 2× SYBR green PCR master mix (Applied Biosystems) according to manufacturer's protocol. To quantify the amount of specific mRNA in the samples, a standard curve was generated for each run using the plasmid (pGEM-T Easy Vector; Promega) containing the gene of interest. This enabled standardization of the initial mRNA content of MBEC4 cells relative to the amount of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). PCR was performed using xCT, 4F2hc, or GAPDH-specific primers, and the cycling parameters are those given above. The specific primers for xCT and 4F2hc are those listed above and for GAPDH as follows: the sense sequence was 5'-TGATGACATCAAGAAGGTGGTGAAG-3', and antisense sequence was 5'-TCCTTGGAGGCCATGTAGGCCAT-3'.
Determination of Intracellular Glutathione.
Measurement of
the total glutathione of PBS-washed cells using a BIOXYTECH GSH-420 kit
was performed according to manufacturer's protocol (Oxis Research
International, Portland, OR). The method is based on the formation of a
chromophoric thione (Griffith, 1980
). Protein assay was performed with
a DC protein assay kit (Bio-Rad, Hercules, CA) with bovine serum
albumin as a standard.
[14C]L-Cystine and
[3H]L-Glutamic Acid Uptake.
L-[U-14C]Cystine
([14C]L-cystine, 303 mCi/mmol;
PerkinElmer Life Sciences, Boston, MA) or
L-[2,3-3H]glutamic acid
([3H]L-Glu, 24 Ci/mmol; PerkinElmer
Life Sciences) uptake was measured according to a previous report
(Terasaki et al., 1991
). Cells (5 × 10 4 cells/cm2) were cultured at 37°C for 2 days on
a 24-well plate (BD Biosciences, San Jose, CA) and washed with 1 ml of
extracellular fluid (ECF) buffer consisting of 122 mM NaCl, 25 mM
NaHCO3, 3 mM KCl, 1.4 mM
CaCl2, 1.2 mM MgSO4, 0.4 mM
K2HPO4, 10 mM
D-glucose, and 10 mM Hepes (pH 7.4) at 37°C. Uptake was
initiated by applying 200 µl of ECF buffer containing 0.1 µCi of
[14C]L-cystine (1.7 µM) or 0.5 µCi of [3H]L-Glu (104 nM) at
37°C in the presence or absence of inhibitors. Na+-free ECF buffer was prepared by equimolar
replacement of NaCl and NaHCO3 with choline
chloride and choline bicarbonate, respectively. After a predetermined
time period, uptake was terminated by removing the solution and then
immersing cells in ice-cold ECF buffer. The cells were then solubilized
in 750 µl of 1% Triton X-100/PBS. An aliquot (15 µl) was taken for
protein assay using a DC protein assay kit with bovine serum albumin as
a standard. The remaining solution (500 µl) was mixed with 5 ml of
scintillation cocktail (Hionic-Fluor; Packard BioScience, Meriden, CT)
for measurement of radioactivity in a liquid scintillation counter
(LS6500; Beckman Coulter Inc., Fullerton, CA).
Data Analysis.
For kinetic studies, the Michaelis-Menten
constant (Km) and maximum uptake rate
(Vmax) of
L-cystine or L-Glu uptake
were calculated from eq. 1 using the nonlinear least-squares regression
analysis program, MULTI (Yamaoka et al., 1981
).
|
(1) |
|
(2) |
| |
Results |
|---|
|
|
|---|
Carrier-Mediated Uptake of L-Cystine by MBEC4
Cells.
The time courses of
[14C]L-cystine uptake by MBEC4
cells are shown in Fig. 1.
[14C]L-Cystine uptake was increased
linearly for at least 30 min at 37°C. The
[14C]L-cystine uptake
(cell-to-medium ratio) was 239 ± 23 µl/mg of protein and
644 ± 60 µl/mg of protein at 10 and 30 min, respectively. At
4°C and 30 min, [14C]L-cystine
uptake was reduced by 97.6% (15.4 ± 1.8 µl/mg of protein) (Fig. 1). Under Na+-free conditions,
L-cystine uptake remained unchanged compared with that in
the presence of Na+ (Table
1). L-Cystine uptake was
saturable with a Km of 63.7 ± 13.9 µM (mean ± S.D.) (Fig. 2A).
Moreover, the Lineweaver-Burk plot showed that the two lines of the
L-cystine uptake in the presence or absence of
160 µM L-Glu intersected the ordinate axis. This indicates that L-Glu competitively inhibited
L-cystine uptake with a
Ki of 83.5 ± 10.3 µM
(mean ± S.D.) (Fig. 2B). These results suggest that
L-cystine uptake by MBEC4 cells is temperature-
and concentration-dependent as well as
Na+-independent. The inhibition study was
performed to characterize the
[14C]L-cystine uptake by
MBEC4 cells (Table 1).
[14C]L-Cystine uptake was
inhibited by more than 90% by L-cystine and
L-Glu in the presence or absence of
Na+ and by L-AAA,
L-homocysteic acid (L-HCA),
and L-quisqualic acid (L-QQA) in the presence of
Na+, all of which are substrates for system
xc
(Sato et al., 1999
).
Partial inhibition was observed by
DL-diaminopimelic acid
(DL-DPA) and L-aspartic
acid (L-Asp) by up to 42%, whereas L-leucine (L-Leu),
L-lysine (L-Lys),
L-arginine (L-Arg),
-aminobutyric acid, and p-aminohippuric acid had no
effect on [14C]L-cystine
uptake.
|
|
|
Carrier-Mediated Uptake of L-Glutamic Acid by MBEC4
Cells.
Although L-Glu exhibited competitive inhibition
of L-cystine uptake in Fig. 2B,
[3H]L-Glu uptake was performed to
characterize the L-Glu transport of L-cystine
and L-Glu exchange transporter, system
xc
, in MBEC4 cells. Figure
3 shows the time courses of
[3H]L-Glu uptake by MBEC4 cells in
the presence or absence of Na+ at 37 and 4°C.
[3H]L-Glu uptake was increased
linearly for at least 30 min in the presence or absence of
Na+ at 37°C. The cell-to-medium ratio of
[3H]L-Glu at 30 min was 1110 ± 140 µl/mg of protein and 123 ± 13 µl/mg of protein in the
presence and absence of Na+, respectively. In
contrast, at 4°C, the cell-to-medium ratio of
[3H]L-Glu at 30 min was 4.66 ± 0.59 µl/mg of protein. This was reduced by 99.6 and 96.2%
compared with that in the presence and absence of
Na+ at 37°C, respectively. Although this
suggests that L-Glu uptake by MBEC4 cells exhibits both
Na+-dependent and -independent processes, a
further study was performed under Na+-free
conditions because system xc
has been reported by others to be Na+-independent
(Sato et al., 1999
), and this is shown in Table 1. [3H]L-Glu uptake in the absence of
Na+ was saturable with a
Km of 48.1 ± 14.2 µM
(mean ± S.D.) (Fig. 4A). A
Lineweaver-Burk plot showed that the two lines of the
L-Glu uptake in the presence or absence of 100 µM L-cystine intersected the ordinate axis.
This indicates that L-cystine competitively inhibited L-Glu uptake with a
Ki of 24.9 ± 3.5 µM (mean ± S.D.) (Fig. 4B). Table 2 shows the
inhibitory effect of several amino acids on
[3H]L-Glu uptake at 5 min. [3H]L-Glu uptake by
MBEC4 cells was inhibited by more than 90% by L-Glu, L-cystine,
L-AAA, L-HCA, and
L-QQA. It was partially inhibited (50%) by
L-Asp, whereas L-Leu and
L-Arg had no effect on
[3H]L-Glu uptake.
|
|
|
Expression of xCT and 4F2hc mRNA in MBEC4 Cells.
The
expression of xCT and 4F2hc mRNA in MBEC4 cells was analyzed by RT-PCR.
The bands corresponding to the expected 182 and 141 base pairs for xCT
and 4F2hc, respectively, were amplified from MBEC4 cells and mouse
brain as a positive control (lane 1) (Fig.
5). The DNA sequence of the bands of
MBEC4 cells was identical to mouse xCT (Sato et al., 1999
) and 4F2hc
(Parmacek et al., 1989
) with a homology of 100%.
|
Effect of DEM on System xc
Expression in
MBEC4 Cells.
The effect of DEM treatment for 12 h on mRNA
expression, [14C]L-cystine uptake,
and glutathione concentration was examined in MBEC4 cells. The
expression of xCT mRNA was significantly increased up to 500 µM in a
concentration-dependent manner for DEM treatment, whereas 4F2hc was
unchanged (Fig. 6A). Corresponding to xCT
mRNA expression, [14C]L-cystine
uptake was enhanced up to 500 µM in a concentration-dependent manner
for DEM treatment (Fig. 6B). The intracellular glutathione concentration correlated with the L-cystine uptake rate
(r 2 = 0.80) (Fig.
7). The xCT mRNA level,
[14C]L-cystine uptake
activity, and intracellular glutathione concentration following 12 h of 500 µM DEM treatment were 2.88-, 2.20-, and 1.44-fold greater
than that of the control (no treatment), respectively.
|
|
| |
Discussion |
|---|
|
|
|---|
The present study demonstrates that MBEC4 cells used as an in
vitro model of the BBB express xCT and 4F2hc mRNA (Fig. 5), and
L-cystine and L-Glu uptakes via system
xc
are
Na+-independent and concentration-dependent
(Figs. 1-4). The Km value for
L-cystine uptake is 63.7 µM (Fig. 2), which is
very similar to those of 70 and 81 µM reported in cultured human
umbilical vein endothelial cells (Miura et al., 1992
) and mouse xCT and 4F2hc cRNA-coinjected Xenopus laevis oocytes, respectively
(Sato et al., 1999
). The Km value for
L-Glu is 48.1 µM (Fig. 4), which is 4.2-fold
smaller than that of 200 µM in cultured human fibroblasts (Bannai and
Kitamura, 1980
). Nevertheless, mutual inhibition was observed for
L-cystine and L-Glu uptake
by MBEC4 cells. The
[14C]L-cystine uptake was
competitively inhibited by 160 µM L-Glu with a
Ki of 83.5 µM (Fig. 2B), which is
comparable with the Km value of
L-Glu uptake in this study. The
[3H]L-Glu uptake was also
competitively inhibited by 100 µM L-cystine with a Ki of 24.9 µM (Fig. 4B),
which is comparable with the Km value
of L-cystine uptake in this study. These results
support the hypothesis that both L-cystine and
L-Glu uptake is mediated via system
xc
in MBEC4 cells. Moreover,
the uptake of both
[14C]L-cystine and
[3H]L-Glu is strongly
inhibited by system xc
substrates, such as L-AAA,
L-HCA, and L-QQA (Tables 1
and 2). This manner of inhibition is consistent with system
xc
characteristics as reported
elsewhere (Miura et al., 1992
; Sato et al., 1999
). System
b0,+, which is also an
Na+-independent transporter, mediates the
transport of L-cystine, L-Leu, and basic amino acids (Pfeiffer et al.,
1999
). [14C]L-Cystine
uptake by MBEC4 cells excludes the involvement of system
b0,+ since L-Leu,
L-Lys, and L-Arg produced
no marked inhibition (Table 1). Na+-dependent
L-Glu uptake is present in MBEC4 cells (Fig. 3),
and this suggests that an Na+-dependent
L-Glu and L-Asp
transporter, system XAG
, is
involved in L-Glu transport in the presence of
Na+ since excitatory amino acid
transporter subtypes 1~3 are expressed at the BBB (O'Kane et al.,
1999
). Although L-Asp and
DL-DPA are dicarboxylic amino acids like
L-Glu and L-cystine, the
inhibition ratio was lower than that of L-Glu and
L-cystine. It seems that these amino acids have a
lower affinity for system xc
than L-Glu and L-cystine
since L-Asp and DL-DPA
have, respectively, shorter and longer carbon chains than
L-Glu (Tables 1 and 2).
Our previous in vivo study indicated that
[14C]L-cystine uptake by the brain
following a 12-h DEM infusion (7.5 µM) via the external carotid
artery was significantly increased (1.6-fold), compared with saline
infusion (Hosoya et al., 2001
). In the presence of L-Glu
and L-AAA,
[14C]L-cystine uptake by the brain
was inhibited by 80% of the amount of enhanced uptake produced by DEM
treatment in the brain, suggesting that system
xc
-mediated
L-cystine transport is activated under oxidative stress conditions at the BBB following DEM treatment. The present study demonstrates the induction and function of the L-cystine
transporter in MBEC4 cells used as an in vitro model for the BBB. DEM
induced xCT mRNA as well as L-cystine uptake in a
concentration-dependent manner following DEM treatment (Fig. 6). This
induction under oxidative stress conditions following DEM treatment is
in good agreement with data in mouse macrophages (Sato et al., 1999
), human glioma cells (Bannai, 1984
), and a rat retinal capillary endothelial cell line (Tomi et al., 2002
). However, the 4F2hc mRNA
level remained unchanged (Fig. 6A), and this is probably due to the
fact that the amount of 4F2hc mRNA was 46-fold greater than xCT mRNA,
according to quantitative real-time RT-PCR analysis under normal
conditions (data not shown). Therefore, the 4F2hc protein is large
enough to bind to xCT protein, although xCT mRNA increased 2.9-fold
following treatment with 500 µM DEM for 12 h. The intercellular
glutathione concentration was also enhanced with increasing
L-cystine uptake by MBEC4 cells (Fig. 7), supporting the
hypothesis that activation of L-cystine uptake via system xc
in MBEC4 cells stimulates
glutathione synthesis in the cells under oxidative stress conditions.
Since [14C]L-cystine uptake by the
brain is activated following DEM infusion in vivo (Hosoya et al.,
2001
), glutathione could be synthesized in brain parenchymal cells
(Sagara et al., 1993
) as well as brain endothelial cells. Although
L-Glu transport from blood to brain can be enhanced due to
induction of system xc
at the
BBB under the oxidative stress conditions, it may not affect
L-Glu levels in the brain. The brain efflux index method has demonstrated that L-Glu undergoes efflux from brain to
blood (Hosoya et al., 1999
). Moreover, O'Kane et al. (1999)
suggested that excitatory amino acid transporter subtypes 1~3 are present on
the abluminal (brain) side of the BBB and mediate brain-to-blood efflux
transport of L-Glu.
A possible physiological role for the induction of system
xc
includes action as a
detoxifying system in the brain and brain capillary endothelial cells
by supplying L-cystine/L-Cys for the synthesis
of glutathione. Maintaining the glutathione concentration in the brain
is essential to support normal CNS functions (Skullerud et al., 1980
).
Therefore, under oxidative stress conditions, system xc
is likely to be induced at
the BBB to supply L-cystine/L-Cys to the brain
as well as the brain endothelial cells. Parkinson's disease,
Alzheimer's disease, dementia, and Huntington's chorea appear to be
associated with oxidative stress in the brain (Karelson et al., 2001
;
Maksimovic et al., 2001
; Serra et al., 2001
) due to a fall in
glutathione levels in neuronal and glial cells (Herrera et al., 2001
).
Therefore, system xc
at the
BBB may play a number of important roles in supplying L-cystine to the brain under oxidative stress conditions
and maintaining the glutathione concentration in the brain to protect
it against CNS disorders. Although Benrabh and Lefauconnier (1996)
have
suggested that system xc
is
not present at the BBB under normal conditions, system
xc
is likely to be induced
under oxidative stress conditions and to stimulate the supply of
L-cystine to the brain. MBEC4 cells express xCT and 4F2hc
mRNA and play a role in L-cystine uptake even under normal
conditions. However, our previous in vivo study indicated that the
apparent influx clearance of
[14C]L-cystine was 3.63 µl/(min · g brain) following a saline infusion (control)
(Hosoya et al., 2001
). This value is 12-fold greater than that of
inulin [0.308 µl/(min · g brain)] (Kakee et al., 1996
),
suggesting that the L-cystine transport system may operate at the BBB and supply L-cystine to the brain under normal
conditions. There are two possible hypotheses to explain this: 1) the
BBB expresses system xc
even
under normal conditions, and 2) MBEC4 cells acquire system xc
during development of this
cell line. Further studies are needed to see whether system
xc
is present at the BBB under
normal conditions in vivo. Taking all these current and previous in
vivo results into consideration, we have shown that
L-cystine undergoes influx transport from the circulating
blood to the brain via system
xc
at the BBB, under oxidative
stress conditions, following DEM treatment to protect the brain from
oxidative damage.
In conclusion, the xCT mRNA level, L-cystine transport activity, and intracellular glutathione level are all enhanced under oxidative stress conditions following DEM treatment of MBEC4 cells used as an in vitro model for the BBB. Our current and previous findings represent an important contribution to a better understanding of the supply of L-cystine to the brain to combat oxidative stress and of the detoxifying and neuroprotective role of the BBB.
| |
Acknowledgments |
|---|
We thank Dr. T. Masuko for valuable discussions and N. Funayama for secretarial assistance.
| |
Footnotes |
|---|
Accepted for publication March 15, 2002.
Received for publication January 31, 2002.
This study was supported, in part, by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan. It was also supported, in part, by The Suzuken Memorial Foundation, The Nakatomi Foundation, The Uehara Memorial Foundation, and The Mochida Memorial Foundation for Medical and Pharmaceutical Research.
Address correspondence to: Professor Tetsuya Terasaki, Department of Molecular Biopharmacy and Genetics, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578, Japan. E-mail: terasaki{at}mail.pharm.tohoku.ac.jp
| |
Abbreviations |
|---|
BBB, blood-brain barrier;
CNS, central nervous
system;
DEM, diethyl maleate;
L-AAA, L-
-aminoadipic acid;
MBEC4, mouse brain endothelial cell
line;
RT-PCR, reverse transcription-polymerase chain reaction;
PBS, phosphate-buffered saline;
GAPDH, glyceraldehyde-3-phosphate
dehydrogenase;
[14C]L-cystine, [U-14C]L-cystine;
[3H]L-Glu, L-[2,3-3H]glutamic acid;
ECF, extracellular
fluid;
L-HCA, L-homocysteic acid;
L-QQA, L-quisqualic acid;
DL-DPA, DL-diaminopimelic acid.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. E. Featherstone and S. A. Shippy Regulation of Synaptic Transmission by Ambient Extracellular Glutamate Neuroscientist, April 1, 2008; 14(2): 171 - 181. [Abstract] [PDF] |
||||
![]() |
H. Augustin, Y. Grosjean, K. Chen, Q. Sheng, and D. E. Featherstone Nonvesicular Release of Glutamate by Glial xCT Transporters Suppresses Glutamate Receptor Clustering In Vivo J. Neurosci., January 3, 2007; 27(1): 111 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Burdo, R. Dargusch, and D. Schubert Distribution of the Cystine/Glutamate Antiporter System xc- in the Brain, Kidney, and Duodenum J. Histochem. Cytochem., May 1, 2006; 54(5): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bridges, H. Hu, S. Miyauchi, U. N. Siddaramappa, M. E. Ganapathy, L. Ignatowicz, D. M. Maddox, S. B. Smith, and V. Ganapathy Induction of Cystine-Glutamate Transporter xc- by Human Immunodeficiency Virus Type 1 Transactivator Protein Tat in Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2906 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Gukasyan, R. Kannan, V. H. L. Lee, and K.-J. Kim Regulation of L-Cystine Transport and Intracellular GSH Level by a Nitric Oxide Donor in Primary Cultured Rabbit Conjunctival Epithelial Cell Layers Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1202 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Mann, D. L. Yudilevich, and L. Sobrevia Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells Physiol Rev, January 1, 2003; 83(1): 183 - 252. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||